Perla Rocío Colunga-Pedraza

20PUBLICATIONS
51CO-AUTHORS
Gene and molecular therapyHaematologyInfant and child healthHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|May 12, 2026
High-Dose methotrexate in pediatric acute lymphoblastic leukemia: Variability across Mexican centers from a national survey.

|Mar 26, 2026
Enhancing Diagnostic Precision in Malignant Hematological Disorders Through Risk Factor Analysis for High-Quality Bone Marrow Aspirate.

Olga G Cantu-Rodriguez, Edgar G Dorsey-Trevino, Alan Contreras-Arce

|Feb 20, 2026
Optimizing Blinatumomab Access for Low- and Middle-Income Countries: Feasibility of a Shortened, Vial-Sharing, Outpatient Approach for Pediatric ALL.

Julia Esther Colunga Pedraza, Andrés Gómez-De León, Perla Rocío Colunga Pedraza

|Dec 15, 2025
Aggressive Sternum Extension in Diffuse Large B-Cell Lymphoma: Barriers to Timely Care in a Resource-Limited Setting.

Anahí Morales-Pedraza, Zulia Guzmán-Martínez, Ana C Tejada-Vásquez

|Nov 24, 2024
Romiplostim, low-dose rituximab and high-dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study.

Perla R Colunga-Pedraza, Fernando De la Garza-Salazar, Héctor A Vaquera-Alfaro

|Nov 19, 2024
Optimizing resources: low-dose nivolumab combinations in the management of relapsed/refractory Hodgkin lymphoma.

Perla R Colunga-Pedraza, Héctor A Vaquera-Alfaro, Zulia Guzmán-Martínez

Pageof 4